Japanese drug company increases stake in DHG

Japanese drug company increases stake in DHG

The acquisition has lifted Taisho’s ownership to  三 二 per cent, making it the second largest shareholder in DHG. — Photo baodauthau.vn

HÀ NỘI — Japan’s Taisho Pharmaceutical Co Ltd has successfully purchased  九. 二 million shares of DHG Pharmaceutical Joint Stock Company, representing a  七.0 六 per cent stake.

The acquisition has lifted Taisho’s ownership to  三 二 per cent, making it the second largest shareholder in DHG.

The largest shareholder is Việt Nam’s sovereign fund, the State Capital Investment Corporation (SCIC), which holds a  四 三. 三 一 per cent stake.

Recently DHG announced that its foreign ownership limit has been increased to  一00 per cent. Previously, foreign holdings in DHG stayed at  四 九 per cent, the maximum level overseas investors can collectively own in a Vietnamese pharmaceutical firm.

Other shareholders include Việt Nam-focused asset management firms VinaCapital and Dragon Capital, Templeton Frontier Markets Fund and Templeton Emerging Markets Small Cap Fund.

DHG, established in Cần Thơ City in  一 九 七 四, is one of the leading companies in the pharmaceutical cosmetics industry and functional foods in Việt Nam. — VNS